TDX METHOTREXATE
K-Number: K830398 · 1983-03-10
Advertisement
Device Summary
Frequently Asked Questions
What is the TDX METHOTREXATE?
TDX METHOTREXATE is a medical device that received FDA 510(k) clearance on 1983-03-10. The listed applicant is Abbott Laboratories. The 510(k) number is K830398.
When did TDX METHOTREXATE receive FDA 510(k) clearance?
TDX METHOTREXATE received FDA 510(k) clearance on 1983-03-10, under 510(k) number K830398.
Who is the listed applicant for TDX METHOTREXATE?
The FDA 510(k) record lists Abbott Laboratories as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for TDX METHOTREXATE?
The FDA product code for TDX METHOTREXATE is LAO.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Abbott Laboratories as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: LAO)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement